|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/06 | (2006.01) |
| A61K 31/55 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07C 309/19 | (2006.01) | ||
| C07C 57/145 | (2006.01) |
| (11) | Number of the document | 3150610 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16183844.6 |
| Date of filing the European patent application | 2011-02-10 | |
| (97) | Date of publication of the European application | 2017-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2019-07-31 |
| (46) | Date of publication of the claims translation | 2019-11-11 |
| (30) | Number | Date | Country code |
| 304277 P | 2010-02-12 | US |
| (72) |
BASFORD, Patricia Ann, GB
CAMPETA, Anthony Michael, US
GILLMORE, Adam, GB
JONES, Matthew Cameron, GB
KOUGOULOS, Eleftherios, US
LUTHRA, Suman, US
WALTON, Robert, GB
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | 8-Fluor-2-{4-[(metilamino}metil]fenil}-1,3,4,5-tetrahidro-6H-azepino[5,4,3-cd]indol-6-ono druskos ir polimorfai |
| SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO}METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[5,4,3-CD]INDOL-6-ONE |
| Payment date | Validity (years) | Amount | |
| 2025-01-23 | 15 | 289.00 EUR |
| 2026-02-10 |